Literature DB >> 28744602

Depression, Metabolic Syndrome, and Locus of Control in Arab Americans Living in the DC Metropolitan Area: A Structural Equation Model.

Nawar M Shara1,2, Alexander Zeymo3, Zeid Abudiab3, Jason G Umans3,4, Soleman Abu-Bader5, Asqual Getaneh3, Barbara V Howard3,4.   

Abstract

Arab Americans have high prevalences of metabolic syndrome (MetS) and depression. Depression and external locus of control (LOC) may worsen MetS. We examined the relationship between depression and MetS with a convenience sample of 136 Arab Americans living in the Washington, DC, metropolitan area. Participants were surveyed with the Multidimensional Health Locus of Control questionnaire and the Center of Epidemiological Studies-Depression scale. Laboratory measurements were collected based on the components of MetS. A structural equation model was used to explore the relationship between MetS and depression through analysis of LOC. MetS was significantly correlated with external LOC (powerful others and chance), and depression was correlated with a weak internal LOC. Future study of the effect of LOC on health outcomes in Arab Americans may be used to mitigate MetS and depression in this population.

Entities:  

Keywords:  Arab Americans; Depression; Locus of control; Metabolic syndrome; SEM

Mesh:

Year:  2018        PMID: 28744602      PMCID: PMC5785563          DOI: 10.1007/s10903-017-0626-0

Source DB:  PubMed          Journal:  J Immigr Minor Health        ISSN: 1557-1912


  37 in total

1.  Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus.

Authors:  S Goya Wannamethee; A Gerald Shaper; Lucy Lennon; Richard W Morris
Journal:  Arch Intern Med       Date:  2005 Dec 12-26

2.  A structural model of racial discrimination, acculturative stress, and cultural resources among Arab American adolescents.

Authors:  Sawssan R Ahmed; Maryam Kia-Keating; Katherine H Tsai
Journal:  Am J Community Psychol       Date:  2011-12

3.  The performance of the Center for Epidemiologic Study Depression Scale (CES-D) in an Arab female community.

Authors:  R Ghubash; T K Daradkeh; K S Al Naseri; N B Al Bloushi; A M Al Daheri
Journal:  Int J Soc Psychiatry       Date:  2000

4.  Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication.

Authors:  Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Kathleen R Merikangas; Ellen E Walters
Journal:  Arch Gen Psychiatry       Date:  2005-06

5.  Measuring depression and stigma towards depression and mental health treatment among adolescents in an Arab-American community.

Authors:  R M Jaber; M Farroukh; M Ismail; J Najda; H Sobh; A Hammad; G W Dalack
Journal:  Int J Cult Ment Health       Date:  2015

6.  Increasing prevalence of the metabolic syndrome among u.s. Adults.

Authors:  Earl S Ford; Wayne H Giles; Ali H Mokdad
Journal:  Diabetes Care       Date:  2004-10       Impact factor: 19.112

7.  Prevalence and trends of metabolic syndrome in the adult U.S. population, 1999-2010.

Authors:  Hiram Beltrán-Sánchez; Michael O Harhay; Meera M Harhay; Sean McElligott
Journal:  J Am Coll Cardiol       Date:  2013-06-27       Impact factor: 24.094

8.  Metabolic syndrome in the Middle East.

Authors:  Hamdy Ahmed Sliem; Seham Ahmed; Nader Nemr; Iman El-Sherif
Journal:  Indian J Endocrinol Metab       Date:  2012-01

9.  Health-related behavior, profile of health locus of control and acceptance of illness in patients suffering from chronic somatic diseases.

Authors:  Konrad Janowski; Donata Kurpas; Joanna Kusz; Bozena Mroczek; Tomasz Jedynak
Journal:  PLoS One       Date:  2013-05-10       Impact factor: 3.240

10.  Depression: an important comorbidity with metabolic syndrome in a general population.

Authors:  James A Dunbar; Prasuna Reddy; Nathalie Davis-Lameloise; Benjamin Philpot; Tiina Laatikainen; Annamari Kilkkinen; Stephen J Bunker; James D Best; Erkki Vartiainen; Sing Kai Lo; Edward D Janus
Journal:  Diabetes Care       Date:  2008-10-03       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.